Skip to content
★ Sign in to follow
SciSparc Ltd. logo

SciSparc Ltd. Stock: price and insider trades · United States

US·Mcap US$39.2MHealth Care

SciSparc Ltd.: what insiders have been doing

Insider filings for SciSparc Ltd. are scarce in the SEC (Form 4) feed, the latest one published on 22 June 2026. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Key facts

Headquarters: Israel

Source: Wikidata (CC0).

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 22,141 of 26,897 companies
28.8
score / 100
Value
12
Quality
45
FCF yld-11%
Earn yld-31%
EV/EBITDA·
ROE-164%
Gross mgn74%
Net mgn·
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$1.70
Analyst consensus
·
Income statement
RevenueUS$856k
Gross profitUS$631k74% margin
EBITDA-US$12.3M-1439% margin
Net income-US$12.2M-1422.8% margin
Valuation
PER (trailing)0.0x
P/Book0.3x
Beta2.55
Balance sheet & cash
Market capUS$39.2M
Total debtUS$366k
Free Cash Flow-US$4.1M
Debt / Equity24%
Profitability & ownership
ROE-164.5%
ROA-26.0%
% institutions9.3%
Last declaration on 22 June 2026
Declarations1 total
  • ●
    10% StockholderExecutives
    583,881 USD10Source
    73,909 shares@ US$7.90100.0% of flowCommonSEC144:0001959173-26-004797

1 of 1 declaration

About SciSparc Ltd.

SciSparc Ltd. is a company focused on developing treatments for neurological diseases. It is listed on the NASDAQ under the ticker SPRC.